Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Preclinical dose-ranging studies of a novel dry powder norovirus vaccine formulation.
Vaccine. 2016 Mar 14;34(12):1452-8. doi: 10.1016/j.vaccine.2016.01.064. Epub 2016 Feb 10.
Vaccine. 2016.
PMID: 26873053
Free PMC article.
Intranasal delivery of a bivalent norovirus vaccine formulated in an in situ gelling dry powder.
Ball JP, Springer MJ, Ni Y, Finger-Baker I, Martinez J, Hahn J, Suber JF, DiMarco AV, Talton JD, Cobb RR.
Ball JP, et al. Among authors: dimarco av.
PLoS One. 2017 May 18;12(5):e0177310. doi: 10.1371/journal.pone.0177310. eCollection 2017.
PLoS One. 2017.
PMID: 28545100
Free PMC article.
Item in Clipboard
CCL5 promotes breast cancer recurrence through macrophage recruitment in residual tumors.
Walens A, DiMarco AV, Lupo R, Kroger BR, Damrauer JS, Alvarez JV.
Walens A, et al. Among authors: dimarco av.
Elife. 2019 Apr 16;8:e43653. doi: 10.7554/eLife.43653.
Elife. 2019.
PMID: 30990165
Free PMC article.
Item in Clipboard
APOBEC Mutagenesis Inhibits Breast Cancer Growth through Induction of T cell-Mediated Antitumor Immune Responses.
DiMarco AV, Qin X, McKinney BJ, Garcia NMG, Van Alsten SC, Mendes EA, Force J, Hanks BA, Troester MA, Owzar K, Xie J, Alvarez JV.
DiMarco AV, et al.
Cancer Immunol Res. 2022 Jan;10(1):70-86. doi: 10.1158/2326-6066.CIR-21-0146. Epub 2021 Nov 18.
Cancer Immunol Res. 2022.
PMID: 34795033
Free PMC article.
Item in Clipboard
In Vivo Modeling of Tumor Heterogeneity for Immuno-Oncology Studies: Failures, Improvements, and Hopes.
DiMarco AV, Maddalo D.
DiMarco AV, et al.
Curr Protoc. 2022 Mar;2(3):e377. doi: 10.1002/cpz1.377.
Curr Protoc. 2022.
PMID: 35255200
Item in Clipboard
APOBEC3 activity promotes the survival and evolution of drug-tolerant persister cells during acquired resistance to EGFR inhibitors in lung cancer.
Garcia NMG, Becerra JN, McKinney BJ, DiMarco AV, Wu F, Fitzgibbon M, Alvarez JV.
Garcia NMG, et al. Among authors: dimarco av.
bioRxiv [Preprint]. 2023 Jul 3:2023.07.02.547443. doi: 10.1101/2023.07.02.547443.
bioRxiv. 2023.
PMID: 37461590
Free PMC article.
Preprint.
Item in Clipboard
Cite
Cite